Avadel Pharmaceuticals Plc - Company Profile
Powered by 
All the sales intelligence you need on Avadel Pharmaceuticals Plc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Avadel Pharmaceuticals Plc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Avadel Pharmaceuticals Plc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Avadel Pharmaceuticals Plc (Avadel) is a biopharmaceutical company engaged in the development and commercialization of products for the treatment of narcolepsy.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Avadel’s R&D activities focus on developing treatments for people with narcolepsy. The company focuses on applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. The company completed the pivotal Phase III REST-ON study, a double-blind, randomized, placebo-controlled trial to assess the efficacy and safety of Lumryz in the treatment of excessive daytime sleepiness (EDS) or cataplexy in adults with narcolepsy. In FY2024, the company spent US$15.2 million on its R&D activities, which as a percentage of revenue stood at 8.9% and grew 14.3% YoY.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer